EU Panel Recommends Humira Biosimilars Idacio, Kromeya EU Panel Recommends Humira Biosimilars Idacio, Kromeya

The EMA ' s Committee for Medicinal Products for Human Use has recommended marketing authorization for two biosimilars that are highly similar to Humira (adalimumab, AbbVie).FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news